Education- Uniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine, Bethesda, MD - Doctor of Medicine
- College of the Holy Cross, Worcester, MA - Bachelor of Arts, Major: Chemistry
BiographyCAPT Regis received his commission as Ensign in the U.S. Navy upon matriculation to the Uniformed Services University of the Health Sciences (USU) F. Edward Hébert School of Medicine. He completed his residency in Pediatrics in 1998 as part of the first Joint Class of the National Capital Consortium (NCC) and served his utilization tour at the USNH Guam as a Staff Pediatrician and Head of Pediatrics before returning to NCC to complete a Fellowship in Pediatric Infectious Disease. CAPT Regis completed one year as Chief of Pediatric Infectious Diseases at then National Naval Medical Center Bethesda in 2004 before taking over as Director of Clinical Trials for the Navy’s Malaria Vaccine Program at the Naval Medical Research Center (NMRC) in Silver Spring, MD where he was responsible for testing one of the first adenovirus vectored malaria vaccines in humans. He then went on to complete Undersea Medical Officer training and was assigned to various Undersea Medicine research positions including Head of Biomedical Research at the Navy Experimental Diving Unit, Panama City, FL and Head of Undersea Medicine at NMRC where under his leadership the program expanded its research portfolio to include a new alternobaric research suite. He was then selected for a two year tour as an Undersea Medicine Exchange Officer to the Royal Navy at the Institute of Naval Medicine in Alverstoke, UK after which he successfully screened and was assigned as the Executive Officer to the Naval Submarine Medical Research Laboratory, Groton, CT. He currently serves at the Naval Sea Systems Command as the UMO for the Navy Supervisor of Diving & Salvage (SUPSALV) as well as the Program Manager for the Deep Submergence Biomedical Development Program. He is also a voting member of the Navy Bureau of Medicine Undersea Medicine Working Group. He has taught various lectures at USU in infectious diseases and diving medicine and has served as a member of the NASA Human Research Program Human Health Countermeasures Decompression Sickness Risk Standing Review Panel among other committees.
Representative publications, projects, and/or deployments
Prior USN Diving Medical Exchange Officer with the British Royal Navy, Portsmouth, UK
Member of NASA Human Research Program Human Health Countermeasures Decompression Sickness Risk Standing Review Panel
Qualified as Submarine, Diving and Saturation Diving Medical Officer
Certified in Tropical & Travel Medicine – American Society of Tropical Medicine & Hygiene
Tested the first Adenovirus-5-vectored malaria vaccine for the Navy
Forbes AS, Regis DP, Hall AA, Mahon RT, Cronin WA Propranolol Effects on Decompression Sickness in a Simulated DISSUB Rescue in Swine Aerosp Med Hum Perform. 2017; 88(4):385–391
Petersen K, Regis DP Safety of Antimalarial Medications for Use while Scuba Diving in Malaria Endemic Regions. Tropical Diseases, Travel Medicine and Vaccines 2016; 2:23
Cronin WA, Senese AL, Arnaud FG, Regis DP, Auker CR, Mahon RT The effect of the perfluorocarbon emulsion Oxycyte on platelet count and function in the treatment of decompression sickness in a swine model. Blood Coagul Fibrinolysis 2016; 27(6):702-710
Sheppard RL, Regis DP, Mahon RT Dodecafluoropentane (DDFPe) and Decompression Sickness-Related Mortality in Rats Aerosp Med Hum Perform. 2015; 86(1):21-26.
Richard T. Mahon and David P. Regis Decompression and Decompression Sickness Compr Physiol 4:1157-1175, 2014
Seth Y. Flagg, David P. Regis, Kyle Petersen, Richard T. Mahon Interrupted oxygen pre-breathing and decompression outcomes in swine. Aviat Space Environ Med 84 (1), January 2013 , 12-16(5)
Tamminga C, Sedegah M, Regis D, Chuang I, Epstein JE, Spring M, Mendoza-Silveiras J, McGrath S, Maiolatesi S, Reyes S, Steinbeiss V, Fedders C, Smith K, House B, Ganeshan H, Lejano J, Abot E, Banania GJ, Sayo R, Farooq F, Belmonte M, Murphy J, Komisar J, Williams J, Shi M, Brambilla D, Manohar N, Richie NO, Wood C, Limbach K, Patterson NB, Bruder JT, Doolan DL, King CR, Diggs C, Soisson L, Carucci D, Levine G, Dutta S, Hollingdale MR, Ockenhouse CF, Richie TL. Adenovirus-5-vectored P. falciparum vaccine e
Sedegah M, Tamminga C, McGrath S, House B, Ganeshan H, Lejano J, Abot E, Banania GJ, Sayo R, Farooq F, Belmonte M, Manohar N, Richie NO, Wood C, Long CA, Regis D, Williams FT, Shi M, Chuang I, Spring M, Epstein JE, Mendoza-Silveiras J, Limbach K, Patterson NB, Bruder JT, Doolan DL, King CR, Soisson L, Diggs C, Carucci D, Dutta S, Hollingdale MR, Ockenhouse CF, Richie TL. PLoS One. 2011;6(10):e24586
Regis, DP Manned Testing of the “Standard Configuration” Divex Shadow Excursion UBA for the USMC, NEDU Technical Report 10-05, May 2010
Regis, DP, Dobaño, C, Quiñones-Olson, P, Liang, X, Graber, NL, Stefaniak, ME, Campo, JJ, Carucci, DJ, Roth, DA, He, H, Felgner, PL, Doolan, DL Transcriptionally Active Pcr For Antigen Identification And Vaccine Development: In Vitro Genome-Wide Screening And In Vivo Immunogenicity. Molecular and Biochemical Parasitology 158(1):32-45 (2008).